Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text

Medicine, Neurology, Neuroscience +10

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

Tarek A Yousry, Eugene O. Major, Caroline F. Ryschkewitsch et al. · New England Journal of Medicine · 2006 · 792 citations · Full text

Medicine, Infectious Diseases, Neurology +14

Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors

Adrian Egli, Laura Infanti, Alexis Dumoulin et al. · The Journal of Infectious Diseases · 2009 · 778 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16